In Section A, members will acquire diverse doses and schedules of oral ABBV-744 pill to identify Risk-free dosing routine. Additional individuals are going to be enrolled at the recognized monotherapy dosign routine. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 is going to be specified as "include-on" therapy. https://abbv-744-clinical-trial-p13467.ampblogs.com/5-tips-about-clinical-effectiveness-of-abbv-744-in-aml-patients-you-can-use-today-68810150